Denali Therapeutics (DNLI)
(Delayed Data from NSDQ)
$15.43 USD
+0.47 (3.14%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $15.42 -0.01 (-0.06%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/13/24 |
---|---|
Current Quarter | -0.67 |
EPS Last Quarter | -0.86 |
Last EPS Surprise | -4.88% |
ABR | 1.24 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -2.61 |
Next Year | -2.71 |
EPS (TTM) | -1.08 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 21.00M | 19.50M | 100.77M | 157.60M |
# of Estimates | 7 | 8 | 9 | 8 |
High Estimate | 35.00M | 32.50M | 269.50M | 386.10M |
Low Estimate | 2.50M | 2.50M | 40.00M | 46.82M |
Year ago Sales | 35.14M | 294.12M | 330.53M | 100.77M |
Year over Year Growth Est. | -40.24% | -93.37% | -69.51% | 56.40% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.67 | -0.68 | -2.61 | -2.71 |
# of Estimates | 12 | 10 | 14 | 12 |
Most Recent Consensus | -0.67 | -0.67 | -2.88 | -2.71 |
High Estimate | -0.53 | -0.54 | -1.12 | -1.00 |
Low Estimate | -0.81 | -0.84 | -3.42 | -3.80 |
Year ago EPS | -0.80 | 1.30 | -1.06 | -2.61 |
Year over Year Growth Est. | 16.25% | -152.31% | -146.23% | -3.50% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 1 | 1 |
Up Last 60 Days | 4 | 3 | 10 | 6 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 1 | 3 | 3 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.67 | -0.68 | -2.61 | -2.71 |
7 Days Ago | -0.67 | -0.68 | -2.61 | -2.71 |
30 Days Ago | -0.67 | -0.68 | -2.62 | -2.71 |
60 Days Ago | -0.92 | -0.78 | -2.86 | -2.65 |
90 Days Ago | -0.92 | -0.78 | -2.93 | -2.68 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.67 | -0.68 | -2.88 | -2.71 |
Zacks Consensus Estimate | -0.67 | -0.68 | -2.61 | -2.71 |
Earnings ESP | 0.00% | 0.00% | -10.19% | -0.19% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.86 | -0.72 | 1.30 | -0.80 | NA |
Estimate | -0.82 | -0.83 | -0.86 | -0.71 | NA |
Difference | -0.04 | 0.11 | 2.16 | -0.09 | 0.54 |
Surprise | -4.88% | 13.25% | 251.16% | -12.68% | 61.71% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more